n-3 PUFA: bioavailability and modulation of adipose tissue function.
about
N-3 Polyunsaturated Fatty Acids and Inflammation in Obesity: Local Effect and Systemic BenefitReducing the burden of obesity-associated cancers with anti-inflammatory long-chain omega-3 polyunsaturated fatty acidsOmega-3 fatty acids for breast cancer prevention and survivorshipAltered lipid metabolism in residual white adipose tissues of Bscl2 deficient miceGenomic and metabolic responses to methionine-restricted and methionine-restricted, cysteine-supplemented diets in Fischer 344 rat inguinal adipose tissue, liver and quadriceps muscleMetabolic effects of n-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: possible role of endocannabinoidsNutritional approaches for managing obesity-associated metabolic diseases.The Associations between Circulating Bile Acids and the Muscle Volume in Patients with Non-alcoholic Fatty Liver Disease (NAFLD)Metabolic switching of human myotubes is improved by n-3 fatty acidsAMP-activated protein kinase α2 subunit is required for the preservation of hepatic insulin sensitivity by n-3 polyunsaturated fatty acids.Why and How Meet n-3 PUFA Dietary Recommendations?The role of adipose tissue in mediating the beneficial effects of dietary fish oilLasting effects on body weight and mammary gland gene expression in female mice upon early life exposure to n-3 but not n-6 high-fat diets.Diet and gene interactions influence the skeletal response to polyunsaturated fatty acidsPathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease.Nutritional ingredients modulate adipokine secretion and inflammation in human primary adipocytes.AMP-activated protein kinase is required for the anti-adipogenic effects of alpha-linolenic acidThe inhibition of fat cell proliferation by n-3 fatty acids in dietary obese miceMetabolic responses to high-fat diets rich in n-3 or n-6 long-chain polyunsaturated fatty acids in mice selected for either high body weight or leanness explain different health outcomesPlasma diacylglycerol composition is a biomarker of metabolic syndrome onset in rhesus monkeys.Supplementation of krill oil with high phospholipid content increases sum of EPA and DHA in erythrocytes compared with low phospholipid krill oil.Conjugated linoleic acid or omega 3 fatty acids increase mitochondrial biosynthesis and metabolism in skeletal muscle cells.n-3 PUFA added to high-fat diets affect differently adiposity and inflammation when carried by phospholipids or triacylglycerols in mice.Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies.Eicosapentaenoic and docosahexaenoic acid supplementation and inflammatory gene expression in the duodenum of obese patients with type 2 diabetes.Obesity polymorphisms identified in genome-wide association studies interact with n-3 polyunsaturated fatty acid intake and modify the genetic association with adiposity phenotypes in Yup'ik peoplePolyunsaturated Fatty acids in children.Effects of dietary eicosapentaenoic acid (EPA) supplementation in high-fat fed mice on lipid metabolism and apelin/APJ system in skeletal muscle.Modulation of adipocyte differentiation by omega-3 polyunsaturated fatty acids involves the ubiquitin-proteasome system.Regulation of adipokine secretion by n-3 fatty acids.Effect of various treatments on leptin, adiponectin, ghrelin and neuropeptide Y in patients with type 2 diabetes mellitus.Role of n-3 fatty acids in muscle loss and myosteatosis.Omega-3 polyunsaturated fatty acids and cancer: lessons learned from clinical trials.Highly purified eicosapentaenoic acid as free fatty acids strongly suppresses polyps in Apc(Min/+) mice.Augmenting energy expenditure by mitochondrial uncoupling: a role of AMP-activated protein kinase.Dietary DHA: time course of tissue uptake and effects on cytokine secretion in mice.Dietary patterns and risk of elevated C-reactive protein concentrations 12 years later.Differential effects of walnuts vs almonds on improving metabolic and endocrine parameters in PCOS.EPA blocks TNF-α-induced inhibition of sugar uptake in Caco-2 cells via GPR120 and AMPK.The effects of n-3 long-chain polyunsaturated fatty acid supplementation on AGEs and sRAGE in type 2 diabetes mellitus.
P2860
Q26784504-2C439E51-A3F0-4B84-8D59-4180EC7A4A6CQ28076327-CC952BFC-A4AD-4A3E-8DAD-590EF524586FQ28080498-9E468B08-EEA7-486C-9AE1-7B929E44F74CQ28537585-A34FC716-75A9-4871-A517-8C778F02391CQ28567664-EA7D64A5-7F0B-4A4E-BFDB-533C0B403CB7Q28728625-23311BCB-8956-4A04-8203-3BB780C0467BQ30234850-C3AF830B-EEB7-422A-BB39-445113BEF302Q33760717-D67595C8-5976-4460-9463-6087A0D963CEQ33993155-DF227516-8203-47EB-935D-072FECCF8460Q34237595-B8B66816-D441-4BC5-A7EE-D643AD48B6C2Q34416842-03AFB93D-3059-414A-9F2F-8BBACE8F5747Q34571736-B4B9FAEE-9249-413F-BE42-9A2EB4A59838Q34586113-0D8441CD-7461-41E7-97E5-AC74D93BB9EEQ34703709-45D31C52-A65D-4BE9-ADC3-261F4A2FC048Q35117457-5A3179F8-4942-4945-A238-D7F3955F7CEDQ35131310-FBE19586-6E68-4BF2-8C8D-DF6E0299DCC6Q35175052-B1095459-7EEE-4A8B-B53C-9712BB3F7624Q35183296-C3DB10C2-4BFE-49D5-92DD-EEC5A861650FQ35203686-EB7749C8-7AC7-4C64-BC58-2ACAC74CEB9DQ35886266-EAC8B6A8-22BB-4EF0-9068-51BDE15530F2Q36246506-3D5D2BA2-1ABA-471C-89B6-0C70909C9E5FQ36448426-53CEC793-B1B0-4EB3-AB40-8D104BC58FEAQ36649089-A75F28B6-2AC6-45B4-A910-456D0880A2C0Q36833317-9879E5FD-1D0D-4731-A665-8EBA9F3FE946Q37033222-C0437DF7-502F-45FF-AA87-1D9376216C96Q37126358-1F68EF42-E62C-445D-AA27-21D9C98EAE7CQ37285770-897B1560-CB84-4FB1-BD07-6D9A712795F8Q37288696-4A772C15-BB5C-40EA-9295-1A837D479529Q37724014-627E38BD-5CBD-486F-91FC-A852A91C70F4Q37764377-4C3C5001-B7AF-4B86-8F1F-3442B7DD7EF8Q37831911-A7B8C9E2-50B6-4A1C-9AF9-326FB39D83F3Q38215558-738AAEEC-0F18-4B88-9047-FEC075AF33FAQ38557891-2DA8E6B3-7A4A-4ACA-B624-C8F7C6CDCA71Q41954579-1EA34A1B-56D7-4E0D-BFF2-2D65F5BFBEEFQ42209652-CE90174F-3618-4898-8E41-CE0EC60C6C97Q43058332-FA6711EE-7628-4BE5-B5E2-A132A61F83D1Q43798056-6F035613-104F-47A8-8656-26D4D2AA2F82Q45958344-471DBDCF-FC12-4908-901A-D9A1940FD289Q47995264-577709B2-C395-4855-9102-1B908411C69CQ51281402-4A766A6A-0B00-47AE-8CC2-F4955C7E8ADC
P2860
n-3 PUFA: bioavailability and modulation of adipose tissue function.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
n-3 PUFA: bioavailability and modulation of adipose tissue function.
@en
n-3 PUFA: bioavailability and modulation of adipose tissue function.
@nl
type
label
n-3 PUFA: bioavailability and modulation of adipose tissue function.
@en
n-3 PUFA: bioavailability and modulation of adipose tissue function.
@nl
prefLabel
n-3 PUFA: bioavailability and modulation of adipose tissue function.
@en
n-3 PUFA: bioavailability and modulation of adipose tissue function.
@nl
P2093
P2860
P50
P1476
n-3 PUFA: bioavailability and modulation of adipose tissue function
@en
P2093
Jan Kopecky
Martin Rossmeisl
Morten Bryhn
Pavel Flachs
Petr Brauner
Zuzana Jilkova
P2860
P304
P356
10.1017/S0029665109990231
P577
2009-08-24T00:00:00Z